Co-infections in people with COVID-19: a systematic review and meta-analysis.

Cited by (1,000)

Items 701–800 of 1,000

1. Fungal complications with the new coronavirus infection COVID-19
   Авдеева Марина Геннадьевна, Зотов Сергей Викторович, Кулбужева Макка Ибрагимовна, Мошкова Дарья Юрьевна, Yelena V. Zhuravleva · 2022 · Epidemiology and Infectious Diseases
2. Biofilms possibly harbor occult SARS-CoV-2 may explain lung cavity, re-positive and long-term positive results
   Daqian He, Chaojiang Fu, Mingjie Ning, Xianglin Hu, Shanshan Li, Ying Chen · 2022 · Frontiers in Cellular and Infection Microbiology
3. Meropenem population pharmacokinetics and model-based dosing optimisation in patients with serious bacterial infection
   Irena Murínová, Martin Švidrnoch, Tomáš Gucký, David Řezáč, Jan Hlaváč, Ondřej Slanař, Martin Šíma · 2022 · European Journal of Hospital Pharmacy
4. Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19
   Jiyoung Lee, Euijin Chang, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sung‐Han Kim, Sang‐Oh Lee, Sang‐Ho Choi, Yang Soo Kim, Seongman Bae · 2023 · Journal of Korean Medical Science
5. Using model systems to unravel host– Pseudomonas aeruginosa interactions
   Shannen L. Grandy, Michal Scur, Kathleen Dolan, Rhea Nickerson, Zhenyu Cheng · 2023 · Environmental Microbiology
6. Bacterial Co- or Superinfection in Patients Treated in Intensive Care Unit with COVID-19- and Influenza-Associated Pneumonia
   Jochen Johannes Schoettler, Stany Sandrio, Christoph Boesing, Lena Bauer, Thomas Miethke, Manfred Thiel, Joerg Krebs · 2023 · Pathogens
7. Pharmacoepidemiological Analysis of Antibacterial Agents Used in a Provisional Hospital in Aktobe, Kazakhstan, in the Context of COVID-19: A Comparison with the Pre-Pandemic Period
   Aigerim Balapasheva, Gaziza Smagulova, A.Z. Mussina, Лилия Евгеньевна Зиганшина, Zhansulu Nurgaliyeva · 2023 · Antibiotics
8. The role of microbial biofilms in the development of respiratory system complications in patients with COVID-19: A literature review
   Олена Володимирівна Кочнєва, O. V. Kotsar · 2023 · Bulletin Of Medical And Biological Research
9. Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains
   Roy H. Rhodes, Gordon L. Love, Fernanda Da Silva Lameira, Maryam Sadough Shahmirzadi, Sharon Fox, Richard S. Vander Heide · 2024 · Diagnostic Pathology
10. Co-Infection of SARS-CoV-2 and Klebsiella pneumoniae: A Systematic Review and Meta-Analysis
    Angélica de Lima das Chagas, Joilma Cruz da Silva Araújo, Jaqueline Correia Pontes, Kelliane Martins de Araújo, Marcos de Oliveira Cunha, Amanda dos Reis Correia, Laura Maria Barbosa Gonçalves, Lí­lian Carla Carneiro · 2024 · Diagnostics
11. Repositioning of Antibiotics in the Treatment of Viral Infections
    Anaíd Bustos-Hamdan, Jair Isidoro Bracho-Gallardo, Aida Hamdan‐Partida, Jaime Bustos‐Martínez · 2024 · Current Microbiology
12. Retrospective review analysis of COVID-19 patients co-infected with Mycoplasma pneumoniae
    Abhinav Choubey, Diaeddin Sagar, Philippa Cawley, Katherine Miller · 2021 · Lung India
13. A retrospective antibiotic prescribing assessment and examination of potential antibiotic stewardship targets in patients with COVID-19
    Ryan W. Stevens, Kelsey L. Jensen, Kirstin J. Kooda, Kristin C. Mara, John Charles O’Horo, Aditya Shah · 2021 · JAC-Antimicrobial Resistance
14. Bacterial infections in COVID-19 patients: a review
    Renato Satovschi Grinbaum, Carlos Roberto Veiga Kiffer · 2021 · Revista da Associação Médica Brasileira
15. Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study
    Luca Masotti, Giancarlo Landini, Grazia Panigada, Elisa Grifoni, Roberto Tarquini, Francesco Cei, Barbara Cimolato, Vieri Vannucchi, Massimo Di Pietro, Fiorella Piani et al. · 2022 · International Immunopharmacology
16. Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV
    Patrizia Zappasodi, Chiara M. Cattaneo, Virginia Valeria Ferretti, Roberto Mina, Andrés J.M. Ferreri, Francesco Merli, Margherita Oberti, Mauro Krampera, Alessandra Romano, Caterina Zerbi et al. · 2022 · Hematological Oncology
17. Structure based virtual screening and molecular dynamics of natural anti-biofilm compounds against SagS response regulator/sensor kinase in Pseudomonas aeruginosa
    Santosh Kumar Behera, Amrita Kumari Panda, Rojita Mishra, Arabinda Mahanty, Satpal Singh Bisht · 2022 · Journal of Biomolecular Structure and Dynamics
18. The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study
    Khalid A. Al Sulaiman, Ohoud A. Aljuhani, Hisham A. Badreldin, Ghazwa B. Korayem, Abeer A. Alenazi, Ahlam H. Alharbi, Albandari Alghamdi, Alaa A. Alhubaishi, Ali Faris Altebainawi, Mohammad Bosaeed et al. · 2023 · BMC Infectious Diseases
19. Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study
    Vivaldo Gomes da Costa, Ana Júlia Chaves Gomes, Cíntia Bittar, Dayla Bott Geraldini, Pâmela Jóyce Previdelli da Conceição, Ágata Silva Cabral, Tamara Carvalho, Joice Matos Biselli, Paola Jocelan Scarin Provazzi, Guilherme Rodrigues Fernandes Campos et al. · 2023 · Viruses
20. Epidemiological Characteristics and Outcomes Predictors for Intensive Care Unit COVID-19 Patients in Al-Madinah, Saudi Arabia. Retrospective Cohort Study
    Sari T. S. Alhoufie, Walaa Abdullah Mumena, Naif H. Alsharif, Hatim M. Makhdoom, Yahya Ahmad Almutawif, Khalid Omer Alfarouk, Mohammed Z Alharbi, Khaled Aljabri, Alanoud A. Aljifri · 2023 · Infection and Drug Resistance
21. Co-infection of SARS-CoV-2 and Bordetella bronchiseptica in a young man with idiopathic non-cystic bronchiectasis and vitamin D3 deficiency
    Fahad Ali Faqihi, Abdulrahman Mishaal Alharthy, Pattarin Pirompanich, Alfateh Sayed Nasr Noor, Ahmad Shahzad, Nasir Nasim, Abdullah Balhamar, Ziad Ahmed Memish, Dimitrios Karakitsos · 2020 · Respiratory Medicine Case Reports
22. Basic Critical Care for Management of COVID-19 Patients: Position Paper of the Indian Society of Critical Care Medicine, Part II
    Suresh Ramasubban, Deven Juneja, Subhal Dixit, Pavan Kumar Reddy, Palepu B. N. Gopal, Raymond Dominic Savio, Manoj Kumar Singh · 2020 · Indian Journal of Critical Care Medicine
23. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus
    Irene Coloretti, Giorgio Berlot, Stefano Busani, Francesco Giuseppe De Rosa, Abele Donati, Francesco Forfori, Giacomo Grasselli, Lucia Mirabella, Carlo Tascini, Pierluigi Viale et al. · 2021 · Journal of Clinical Medicine
24. Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study
    Johan Van Laethem, Stephanie C. M. Wuyts, Sven Van Laere, Silke Dirkx, Lucie Seyler, Rembert Mertens, Bart Ilsen, Patrick Lacor, Denis Piérard, Sabine Danielle Allard · 2021 · Infectious Diseases and Therapy
25. Antibiotic resistance of Klebsiella pneumoniae against the background of the COVID-19 pandemic: experience of the multidisciplinary hospital
    D. V. Tapalski, Е. В. Карпова, О.М. Акуленок, В. К. Окулич, Igor I. Generalov, Н.Ю. Лескова, Elena Antonova, Жильцов Иван Викторович, О. В. Осипкина, L. V. Mozharovskaya et al. · 2021 · Infectious diseases News Opinions Training
26. Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?
    Sopirala, Madhuri M. · 2021 · Current Opinion in Infectious Diseases
27. Multiple microbial coinfections occurred during COVID-19 pandemic
    Maneesh Kumar, Ratnesh Kumar, Arti Kumari, Roshan Kamal Topno · 2024 · IP International Journal of Medical Microbiology and Tropical Diseases
28. Tolerance to Haemophilus influenzae infection in human epithelial cells: Insights from a primary cell-based model
    Ulrike Kappler, Anna Henningham, Marufa Nasreen, Ayaho Yamamoto, Andrew H. Buultjens, Timothy Paul Stinear, Peter David Sly, Emmanuelle Fantino · 2024 · PLoS Pathogens
29. Artificial intelligence in antibiotic discovery: Applications, challenges, and future outlook
    Jing Bo Xu, Chen Li, Xiaoyu Wang, Anton Yariv Peleg, FUYI LI, Jiangning Song, César de la Fuente‐Núñez · 2026 · Cell Biomaterials
30. Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
    Wang-Da Liu, Jann‐Tay Wang, Chien‐Ching Hung, Shan‐Chwen Chang · 2021 · Journal of Microbiology Immunology and Infection
31. Salient features of circulating respiratory viruses in the pre- and pandemic influenza and COVID-19 seasons
    Irina Kiseleva, Natalie V. Larionova, Elena Grigorieva, Ксенафонтов Андрей Дмитриевич, Mohammad Al Farroukh, Руденко Лариса Георгиевна · 2021 · Russian Journal of Infection and Immunity
32. Bacterial and fungal communities in tracheal aspirates of intubated COVID-19 patients: a pilot study
    Alicia Ruiz-Rodriguez, Paula Lusarreta Parga, Wouter A. A. de Steenhuijsen Piters, Lilian Koppensteiner, Carlos Balcazar Lopez, Robyn Campbell, Rebecca Dewar, Martin P. McHugh, David Harold Dockrell, Kate E Templeton et al. · 2022 · Scientific Reports
33. Modern view on the etiology and immunological aspects of pneumonia
    Alexey A. Minakov, Vakhlevsky V.V. Vakhlevsky, Волошин Никита Игоревич, Харитонов Михаил Анатольевич, В. В. Салухов, Vadim Vitalyevich Tyrenko, Yu. V. Rudakov, E. N. Vakhlevskaya, E. V. Alekhina · 2023 · Meditsinskiy sovet = Medical Council
34. Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients1
    Davide Mangioni, Liliane Chatenoud, Jacopo Colombo, Emanuele Palomba, Fernando Antonio Arenas Guerrero, Matteo Bolis, Nicola Bottino, Giuseppe Breda, Maria Vittoria Chiaruttini, Gabriele Fior et al. · 2023 · Emerging infectious diseases
35. Skewed perception of personal behaviour as a contributor to antibiotic resistance and underestimation of the risks
    Emily Smith, Sarah L. Buchan · 2023 · PLoS ONE
36. Unveiling the dynamics of antimicrobial utilization and resistance in a large hospital network over five years: Insights from health record data analysis
    Danesh Moradigaravand, Abiola Catherine Senok, Laila Mohamed Jasim Ali AlDabal, Hamda Hassan Khansaheb, Maya Habous, Hanan Sulaiman Al Suwaidi, Alawi A.A. Alsheikh-Ali · 2023 · PLOS Digital Health
37. An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19
    Xavier Durà-Miralles, Gabriela Abelenda-Alonso, Alba Bergas, Júlia Laporte-Amargós, Enric Sastre-Escolà, Ariadna Padullés, Jordi Carratalà, Carlota Gudiol · 2024 · Antibiotics
38. The DmsABC S-oxide reductase is an essential component of a novel, hypochlorite-inducible system of extracellular stress defense in Haemophilus influenzae
    Marufa Nasreen, Daniel J. Ellis, Jennifer Hosmer, Ama‐Tawiah Essilfie, Emmanuelle Fantino, Peter David Sly, Alastair G. McEwan, Ulrike Kappler · 2024 · Frontiers in Microbiology
39. Characteristics of Bacterial Microflora Isolated from Sputum of Patients with Pneumonia Registered in Khabarovsk City and Khabarovsk Territory in the Initial Period of COVID-19 Pandemic in May–June, 2020
    Albina P. Bondarenko, Шмыленко Влада Александровна, Olga Evgenevna Trotsenko, Котова Валерия Олеговна, Liudmila V. Butakova, Базыкина Елена Анатольевна · 2020 · Problems of Particularly Dangerous Infections
40. Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship
    Ombretta Para, Lorenzo Caruso, Mattia Ronchetti, Martina Finocchi, Stefano Guidi, Michele Spinicci · 2020 · Internal and Emergency Medicine
41. Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study
    Daniele Roberto Giacobbe, Chiara Russo, Veronica Martini, Silvia Dettori, Federica Briano, Michele Mirabella, Federica Portunato, Chiara Dentone, Sara Mora, Mauro L. Giacomini et al. · 2021 · Antibiotics
42. Simultaneous Detection of Multiple Respiratory Viruses Among SARS-CoV-2-Positive and Negative Patients by Multiplex TaqMan One-Step Real-Time PCR
    Parsa Veisi, Somayeh Shatizadeh Malekshahi, Hamzeh Choobin, Mohammad Reza Jabbari, Peyman Mohammadi Torbati · 2022 · Jundishapur Journal of Microbiology
43. Ciprofloxacin-Resistant Pseudomonas aeruginosa Lung Abscess Complicating COVID-19 Treated with the Novel Oral Fluoroquinolone Delafloxacin
    Jürgen Panholzer, Matthias J. Neuböck, Guangyu Shao, Sven Heldt, Markus Winkler, Paul Greiner, Norbert Fritsch, Bernd Lamprecht, Helmut J.F. Salzer · 2022 · Case Reports in Pulmonology
44. The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)
    Marco Peradotto, Alessandro Bondi, D. Lombardi, Paolo Bottino, Elisa Zanotto, Anna Maria Barbui, Rossana Cavallo · 2022 · Infection
45. Co-infection of Uropathogenic Escherichia coli among COVID-19 Patients Admitted to a Tertiary Care Centre: A Descriptive Cross-sectional Study
    Ajaya Basnet, Arun Bahadur Chand, Lok Bahadur Shrestha, Nayanum Pokhrel, Lochan Karki, Sailendra Kumar Duwal Shrestha, Basanta Tamang, Mahendra Raj Shrestha, Maina Dulal, Junu Richhinbung Rai · 2022 · Journal of Nepal Medical Association
46. Streptococcus pneumoniae Coinfection in COVID-19 in the Intensive Care Unit: A Series of Four Cases
    Shrey B. Shah, Chaitanya Karlapalem, Pratik Patel, Nikhil Madan · 2022 · Case Reports in Critical Care
47. Risk factors associated with development of coinfection in critically Ill patients with COVID-19
    Erica M. Orsini, Gretchen L. Sacha, Xiaozhen Han, Xiaofeng Wang, Abhijit Duggal, Prabalini Rajendram · 2022 · Acute and Critical Care
48. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Co-Infection in a Stem Cell Transplant Patient
    Michael Pierce, Wendy Slipke, Mark J. Biagi · 2022 · Antibiotics
49. SARS-CoV-2 and Dengue Virus Coinfection in a Mexican Pediatric Patient: A Case Report from Early Molecular Diagnosis
    Eloy Alfonso Zepeda-Carrillo, Francisco Matías Soria-Saavedra, Maria B. Mercado Villegas, Alejandra López Alvarado, José Ángel Regla-Nava, Rafael Torres‐Valadez · 2022 · Pathogens
50. Procalcitonin Values Fail to Track the Presence of Secondary Bacterial Infections in COVID-19 ICU Patients
    Elsa Harte, Sharuha Kumarasamysarma, Benjamin Phillips, Olivia Mackay, Zohra Rashid, Natalya Malikova, Abdullah Mukit, Saraswathi Ramachandran, Anna Biju, Kate Brown et al. · 2023 · Antibiotics
51. Recovering vaccine coverage lost due to the COVID-19 pandemic
    F.A. Moraga Llop, María Fernández-Prada, Ana Ma Grande-Tejada, L.I. Martínez-Alcorta, David Moreno‐Pérez, Jaime Jesús Pérez‐Martín · 2020 · Vacunas (English Edition)
52. The Binary Model of Chronic Diseases Applied to COVID-19
    Zeev Elkoshi · 2021 · Frontiers in Immunology
53. Platypnea Orthodeoxia Due to a Patent Foramen Ovale and Intrapulmonary Shunting After Severe COVID-19 Pneumonia
    Blair K. Dodson, Catherine Kendall Major, Maxwell Grant, Byung Soo Yoo, Benjamin Goodman · 2021 · American Journal of Case Reports
54. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels
    Wonhee So, Matthew S. Simon, Justin J. Choi, Tina Z. Wang, Samuel Clay Williams, Jason Chua, Christine J. Kubin · 2022 · Internal and Emergency Medicine
55. Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study
    Donatella Panatto, Andrea Orsi, Bianca Marisa Bruzzone, Valentina Ricucci, Guido Fedele, Giorgio Reiner, Nadia Giarratana, Alexander Domnich, Giancarlo Icardi, STX Study Group · 2022 · Viruses
56. POLYPHARMACY IN MANAGMENT OF IN-PATIENTS WITH NOVEL CORONAVIRUS DISEASE (COVID-19)
    Vladimir Ivanovich Petrov, A. Yu. Ryazanova, N. S. Privaltseva, D. A. Nekrasov · 2022 · Pharmacy & Pharmacology
57. COVID-19: CRISPR/Cas-like System of nsp3 Promotes the Mutant Recombination and Drug Resistance
    Wenzhong Liu, Li hualan · 2021 · ChemRxiv
58. Candidemia and Severe Coronavirus Disease 2019: Which Risk Factors Are Modifiable?
    Todd P McCarty · 2021 · Clinical Infectious Diseases
59. Single-centre experience of using procalcitonin to guide antibiotic therapy in COVID-19 intensive care patients
    P. Moseley, Niall Jackson, A. Omar, Mohammed Fathi ELdoadoa, C. Samaras, Rubinder Birk, F. Ahmed, P. Chakrabarti · 2021 · Journal of Hospital Infection
60. Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistant Staphylococcus aureus
    Joshua Gentges, Nadeem El-Kouri, Tashrique Rahman, Nasir Mushtaq, Ed Hudson, David Scheck · 2023 · Antimicrobial Stewardship & Healthcare Epidemiology
61. The membrane-cytoplasmic linker defines activity of FtsH proteases in Pseudomonas aeruginosa clone C
    Gina D. Mawla, Shady Mansour Kamal, Lian-Ying Cao, Pasi Purhonen, Hans Hebert, Robert T. Sauer, Tania A. Baker, Ute Römling · 2024 · Journal of Biological Chemistry
62. Recovery of clinically relevant multidrug‐resistant Klebsiella pneumoniae lineages from wastewater in Kumasi Metropolis, Ghana
    Amen Ekhosuehi, Odion O. Ikhimiukor, Helen Michelle Korkor Essandoh, Nana Yaw Asiedu, Isoken Tito Aighewi, Gabriel Temitope Sunmonu, Erkison Ewomazino Odih, Anderson O. Oaikhena, Dorothy Cyril‐Okoh, Clara Yeboah et al. · 2024 · Environmental Microbiology Reports
63. Prevalence and Predictors of Concomitant Bacterial Infections in Patients With Respiratory Viruses in Ontario: A Cohort Study
    Yue Wang, Sarah Swayze, Kevin Antoine Brown, Derek R. MacFadden, Samantha M. Lee, Kevin L. Schwartz, Nick Daneman, Bradley J. Langford · 2024 · Open Forum Infectious Diseases
64. Colistin Treatment Outcomes in Gram-Negative Bacterial Infections in the Northeast of Romania: A Decade of Change Through Pandemic Challenges
    Mădălina Alexandra Vlad, Luminița Smaranda Iancu, Olivia Dorneanu, Alexandru Duhaniuc, Mariana Pavel Tanasa, Cristina Tuchiluş · 2025 · Antibiotics
65. A Retrospective Study of the Impact of the COVID-19 Pandemic on the Utilization and Quality of Antibiotic Use in a Tertiary Care Teaching Hospital in Low-Resource Settings
    Vedrana Barišić, Tijana Kovačević, Maja Travar, Ana Golić-Jelić, Peđja Kovačević, Dragana Milaković, Ranko Škrbić · 2025 · Antibiotics
66. RESISTÊNCIA ANTIMICROBIANA PÓS-COVID-19: REVISÃO DE LITERATURA
    Beatriz Izilda Minante, Giovana Girardi Ticotosti, Isabella Silva Barros, Marcela Bocalete Balieiro, Milena Euzébio Rodrigues da Silva, Cristiane Tefé‐Silva, Karina Furlani Zoccal · 2022 · RECIMA21 - Revista Científica Multidisciplinar
67. Bacterial co-infection raises in-hospital mortality of COVID-19 patients: a retrospective study
    Kaican Zong, Wen Li, Yingya Fu, Sha Zhang, Yi Liu, Shiying Li · 2023 · Frontiers in Microbiology
68. Temporally Associated Invasive Pneumococcal Disease and SARS-CoV-2 Infection, Alaska, USA, 2020–2021
    Katherine Newell, Marc Fischer, Stephanie Massey, Laurie Orell, Jonathan Steinberg, Megan L. Tompkins, Louisa J. Castrodale, Joseph K. McLaughlin · 2023 · Emerging infectious diseases
69. Central Line Associated Bloodstream Infections in Critical Ill Patients during and before the COVID-19 Pandemic
    Soňa Hlinková, Eva Moraučíková, A Lesnakova, Agnieszka Strzelecka, Vladimir Littva · 2023 · Healthcare
70. Gas chromatography-flame ionization detector for sweat based COVID-19 screening
    Nuttanee Tungkijanansin, Sorachar Phusrisom, Kaywalee Chatdarong, Pattama Torvorapanit, Patthrarawalai Sirinara, Thumnoon Nhujak, Chadin Kulsing · 2023 · Analytica Chimica Acta
71. Bacterial Co-Infection in Patients with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescription
    María Fernanda Celaya Corella, Jorge Omer Rodeles Nieblas, Donato Antonio Rechy Iruretagoyena, Gerson Ney Hernández Acevedo · 2023 · Microbiology Research
72. New Phenylthiazoles: Design, Synthesis, and Biological Evaluation as Antibacterial, Antifungal, and Anti‐COVID‐19 Candidates
    Inas G. Shahin, Khaled Omar Mohamed, Azza T. Taher, Mohamed M. Elsebaei, Abdelrahman S. Mayhoub, Asmaa E. Kassab, Ahmed M. ElShewy · 2023 · Chemistry & Biodiversity
73. Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study
    Hans-Jakob Meyer, Lukas Mödl, Olesya Unruh, Weiwei Xiang, Sarah Berger, Moritz Müller-Plathe, Gernot G. U. Rohde, Mathias Wilhelm Pletz, Jan Rupp, Norbert Suttorp et al. · 2024 · Infection
74. Bacterial and Viral Co-Infections in COVID-19 Patients: Etiology and Clinical Impact
    Ivelina T. Trifonova, Iveta Madzharova, Neli Korsun, Victoria Levterova, Petar Velikov, Silvia Voleva, Ivan Ivanov, Daniel Toshkov Ivanov, Ralitsa Yordanova, Tatiana Tcherveniakova et al. · 2024 · Biomedicines
75. Understanding the Molecular Interactions Between Influenza A Virus and Streptococcus Proteins in Co-Infection: A Scoping Review
    Askar K. Alshammari, Meshach Maina, Adam Mark Blanchard, Janet M. Daly, Stephen P. Dunham · 2025 · Pathogens
76. What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web survey helps us to understand where the doubts lie
    Marta Colaneri, Pietro Valsecchi, Marco Vecchia, Alessandro Di Filippo, Valentina Zuccaro, Elena Maria Seminari, Paolo Sacchi, Laura Maiocchi, Massimiliano Fabbiani, Alessandra Ricciardi et al. · 2021 · Journal of Global Antimicrobial Resistance
77. Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review
    Michael L. Behal, Brooke Barlow, Breanne M. Mefford, Melissa L. Thompson Bastin, John C. Donaldson, Melanie E. Laine, Brittany D. Bissell · 2021 · Critical Care Explorations
78. Legionella Coinfection in a Patient With COVID-19 Pneumonia
    Yogesh Subedi, Christopher James Haas · 2021 · Cureus
79. A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK
    Andrew Vyse, James Campling, Carole Czudek, Gillian Ellsbury, Diana Mendes, Ralf-René Reinert, Mary Slack · 2021 · Expert Review of Vaccines
80. Impact of coinfection status and comorbidity on disease severity in adult emergency department patients with influenza B
    Alexander J. Zapf, Justin P. Hardick, Breana McBryde, Lauren M Sauer, Katherine Fenstermacher, Erin P. Ricketts, Yi‐Chin Lin, Kuan‐Fu Chen, Yu‐Hsiang Hsieh, Andrea Freyer Dugas et al. · 2021 · Influenza and Other Respiratory Viruses
81. Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
    Iwein Gyselinck, Laurens Liesenborghs, Ann Belmans, Matthias M. Engelen, Albrecht Betrains, Quentin Van Thillo, Pham Anh Hong Nguyen, Pieter Goeminne, Ann-Catherine Soenen, Nikolaas De Maeyer et al. · 2022 · ERJ Open Research
82. Coinfections and antimicrobial use in patients hospitalized with coronavirus disease 2019 (COVID-19) across a single healthcare system in New York City: A retrospective cohort study
    Prithiv J. Prasad, Jordan Poles, Ioannis M. Zacharioudakis, Yanina Dubrovskaya, Dinuli Delpachitra, Eduardo Iturrate, Sigridh Muñoz-Gómez · 2022 · Antimicrobial Stewardship & Healthcare Epidemiology
83. Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab
    Antonio Ramón, Marta Zaragozá, Ana Torres, J. Cascón, Pilar Blasco, Javier Milara, Jorge Mateo · 2022 · Journal of Clinical Medicine
84. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study
    Elen Vink, Christopher Davis, Alasdair R. MacLean, David J. Pascall, Sarah E McDonald, Rory N. Gunson, Hayley E. Hardwick, Wilna Oosthuyzen, Peter Openshaw, John Kenneth Baillie et al. · 2022 · Open Forum Infectious Diseases
85. Snapshot of COVID-19 superinfections in Marseille hospitals: where are the common pathogens?
    Elisabeth Le Glass, Didier Raoult, Grégory Dubourg · 2022 · Epidemiology and Infection
86. What happened during COVID-19 in African ICUs? An observational study of pulmonary co-infections, superinfections, and mortality in Morocco
    Younès Aïssaoui, Youssef Ennassimi, Ismail Myatt, Mohammed El Bouhiaoui, Mehdi Nabil, Mohammed Bahi, Lamiae Arsalane, Mouhcine Miloudi, Ayoub Belhadj · 2022 · PLoS ONE
87. Impact of Bacterial Infections on COVID-19 Patients: Is Timing Important?
    Christos Michailides, Themistoklis Paraskevas, Iosif Karalis, Ioanna C. Koniari, Charalampos N. Pierrakos, Vasileios Karamouzos, Markos N. Marangos, Dimitrios Velissaris · 2023 · Antibiotics
88. Analysis of coexisting pathogens in nasopharyngeal swabs from COVID-19
    Zhan Gao, Lisong Yu, Ling Cao, Meng Yang, Yuhui Li, Yue Lan, Ruixiang Tang, Yang Huang, Guangxin Luan, Yingfen Liu et al. · 2023 · Frontiers in Cellular and Infection Microbiology
89. Antibiotic use in hospitalized patients with COVID-19: a population-based study in Hong Kong
    Joseph E. Blais, Weixin Zhang, Yun Lin, Celine Sze Ling Chui, Vincent Chi‐Chung Cheng, Benjamin John Cowling, Peng Wu · 2023 · Antimicrobial Stewardship & Healthcare Epidemiology
90. The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study
    Peter Crook, Clare Logan, Andrea Mazzella, Rachel M. Wake, Martina Cusinato, Ting Yee Yau, Yee Ean Ong, Tim Planche, Marina Basarab, Tihana A. Bicanic · 2023 · BMC Infectious Diseases
91. Development of a novel risk score for the prediction of critical illness amongst COVID‐19 patients
    Ioannis Bellos, Panagiota Lourida, Aikaterini Argyraki, Eleni Korompoki, Christina Zirou, Ioanna Kokkinaki, Angelos V. Pefanis · 2020 · International Journal of Clinical Practice
92. Diagnosing COVID-19; towards a feasible COVID-19 rule-out protocol
    Jozefien De Clercq, Thomas L. A. Malfait, Simon Malfait, Jerina Boelens, Liselotte Coorevits, Elizaveta Y. Padalko, Stien Vandendriessche, Bruno Verhasselt, Lieve Morbée, Fré A. Bauters et al. · 2021 · Acta Clinica Belgica
93. Frequency Of Coinfection By Respiratory Pathogens And Its Impact On The Prognosis Of Patients With COVID-19.
    Dante Manuel Quiñones-Laveriano, Alonso Soto, Lucero Quilca-Barrera · 2021 · Revista de la Facultad de Medicina Humana
94. Tendencias en el uso de fármacos para la COVID-19 durante la primera ola de la pandemia en un hospital de Lima, Perú
    Nataly Echevarría-Castro, Danitza Adriana Rojo García, Midori Torpoco Rivers, Paola L. Rondán, Frank García-Rojas, Álvaro Taype-Rondán · 2021 · Revista Peruana de Medicina Experimental y Salud Pública
95. SARS-CoV-2-induced host metabolic reprogram (HMR): nutritional interventions for global management of COVID-19 and post-acute sequelae of COVID-19 (PASC)
    A. Satyanarayan Naidu, Fereidoon Shahidi, Chin‐Kun Wang, Kenji Sato, Aman Wirakartakusumah, Ogugua Charles Aworh, Roger Clemens · 2022 · Journal of Food Bioactives
96. Oral and Maxillofacial Lesions in COVID 19 Infection from Mosul Hospital in Iraq: Epidemiological Study and Approach to Classification and Treatment
    Alyaa I. Naser, Marwa Nazar Al-Sarraj, Ziad Hazim Deleme · 2021 · Journal Of Oral Research
97. The association of smoking status with hospitalisation for COVID-19 compared with other respiratory viruses a year previous: A case-control study at a single UK National Health Service trust
    David Simons, Olga Perski, Lion Shahab, Jamie Brown, Robin L. Bailey · 2020 · medRxiv
98. Analysis of the upper respiratory tract microbiota in mild and severe COVID-19 patients
    Vladislav V. Babenko, Ramiz Bakhtyev, Vladimir P. Baklaushev, Лариса Александровна Балыкова, Pavel V. Bashkirov, Julia Bespyatykh, Anna Sergeevna Blagonravova, Daria I. Boldyreva, D. Fedorov, Ilshat Gafurov et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
99. Epimacular membrane peeling.
    David McLeod, John Kenneth Marshall, Ian Grierson · 1981 · PubMed
100. Effectiveness of Mid-Regional Pro-Adrenomedullin (MR-proADM) as Prognostic Marker in COVID-19 Critically Ill Patients: an Observational Prospective Study
     Giorgia Giuseppina Montrucchio, Gabriele Sales, Francesca Rumbolo, Filippo Palmesino, Vito Fanelli, Rosario Urbino, Claudia Filippini, Giulio Mengozzi, Luca Brazzi · 2020 · Research Square